Cargando…

Endocan and Circulating Progenitor Cells in Women with Systemic Sclerosis: Association with Inflammation and Pulmonary Hypertension

Background: Systemic sclerosis (SSc) is characterized by early vasculopathy and fibrosis in the skin, lungs, and other tissues. Vascular manifestations of SSc include Raynaud’s phenomenon, digital ulcers, and pulmonary artery hypertension (PAH). PAH is the second most common cause of mortality in SS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lo Gullo, Alberto, Mandraffino, Giuseppe, Rodríguez-Carrio, Javier, Scuruchi, Michele, Sinicropi, Davide, Postorino, Maria, Morace, Carmela, Giuffrida, Clemente, Sciortino, Davide, Gallizzi, Romina, Loddo, Saverio, Zito, Concetta, Squadrito, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150353/ https://www.ncbi.nlm.nih.gov/pubmed/34064667 http://dx.doi.org/10.3390/biomedicines9050533

Ejemplares similares

Expression and Change of miRs 145, 221 and 222 in Hypertensive Subjects Treated with Enalapril, Losartan or Olmesartan
por: Mandraffino, Giuseppe, et al.
Publicado: (2021)

Serum endocan as a predictive biomarker of cardiovascular risk in obese pediatric patients
por: Morace, Carmela, et al.
Publicado: (2023)

Abnormal left ventricular global strain during exercise-test in young healthy smokers
por: Mandraffino, Giuseppe, et al.
Publicado: (2020)

Arterial Stiffness and Adult Onset Vasculitis: A Systematic Review
por: Lo Gullo, Alberto, et al.
Publicado: (2022)

Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia
por: Mandraffino, Giuseppe, et al.
Publicado: (2022)

Circulating progenitor cells in hypertensive subjects: Effectiveness of a treatment with olmesartan in improving cell number and miR profile in addition to expected pharmacological effects
por: Mandraffino, Giuseppe, et al.
Publicado: (2017)

Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units
por: Scicali, Roberto, et al.
Publicado: (2022)

PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy
por: Toscano, Arianna, et al.
Publicado: (2022)

Endocan Knockdown Down-Regulates the Expression of Angiogenesis-Associated Genes in Il-1ß Activated Chondrocytes
por: Scuruchi, Michele, et al.
Publicado: (2023)

Endocan Promotes Pro-Tumorigenic Signaling in Lung Cancer Cells: Modulation of Cell Proliferation, Migration and lncRNAs H19 and HULC Expression
por: Aliquò, Federica, et al.
Publicado: (2023)

Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular Disease
por: Aragona, Caterina Oriana, et al.
Publicado: (2016)

Quality of Life (QoL) in Patients with Chronic Inflammatory Bowel Diseases: How Much Better with Biological Drugs?
por: Bellone, Federica, et al.
Publicado: (2023)

Vitamin D Status in Rheumatoid Arthritis: Inflammation, Arterial Stiffness and Circulating Progenitor Cell Number
por: Lo Gullo, Alberto, et al.
Publicado: (2015)

Prevalence of Pulmonary Hypertension in an Unselected Community-Based Population: A Retrospective Echocardiographic Study—RES-PH Study
por: Imbalzano, Egidio, et al.
Publicado: (2021)

Editorial: Chronic rheumatic inflammatory conditions and cardiovascular health
por: Lo Gullo, Alberto, et al.
Publicado: (2022)

Endocan and Erectile Dysfunction
por: Balta, Sevket, et al.
Publicado: (2019)

Association of Systemic Sclerosis and Periodontitis with Vitamin D Levels
por: Isola, Gaetano, et al.
Publicado: (2021)

The Role of Endocan in Cardiometabolic Disorders
por: Klisic, Aleksandra, et al.
Publicado: (2023)

Characteristics of Serum Endocan Levels in Infection
por: Seo, Kazunori, et al.
Publicado: (2015)

Endocan: A novel circulating proteoglycan
por: Kali, Arunava, et al.
Publicado: (2014)

Expressions of Endocan in Patients with Meningiomas and Gliomas
por: Atukeren, Pinar, et al.
Publicado: (2016)

Endocan and the respiratory system: a review
por: Kechagia, Maria, et al.
Publicado: (2016)

The Role of Endocan in Selected Kidney Diseases
por: Nalewajska, Magdalena, et al.
Publicado: (2020)

Are Endocan Plasma Levels Altered in Preeclampsia?
por: Lopes, Ana Cristina dos Santos, et al.
Publicado: (2021)

Serum Endocan Levels in Children with Febrile Neutropenia
por: Kiral, Eylem, et al.
Publicado: (2016)

Serum endocan levels in patients with stable COPD
por: Pihtili, Aylin, et al.
Publicado: (2018)

Circulating endocan and preeclampsia: a meta-analysis
por: Lan, Xia, et al.
Publicado: (2020)

Effects of intermittent hemodialysis on plasmatic levels of endocan
por: Hureau, Maxence, et al.
Publicado: (2021)

Endocan: A Key Player of Cardiovascular Disease
por: Chen, Jinzhi, et al.
Publicado: (2022)

Prognostic and Diagnostic Value of Endocan in Kidney Diseases
por: Samouilidou, Elisabeth, et al.
Publicado: (2022)

Endocan-microvascular Density in Primary Ovarian Carcinoma
por: Baba, Farahlina, et al.
Publicado: (2022)

Immunolocalization of endocan during the endothelial-mesenchymal transition process
por: Carrillo, L.M., et al.
Publicado: (2011)

Serum endocan levels in women with restless legs syndrome
por: Celik, Kenan, et al.
Publicado: (2015)

Plasma endocan level and prognosis of immunoglobulin A nephropathy
por: Lee, Yu Ho, et al.
Publicado: (2016)

Endocan silencing induces programmed cell death in hepatocarcinoma
por: Yang, Jinghui, et al.
Publicado: (2017)

Endocan, sepsis, pneumonia, and acute respiratory distress syndrome
por: De Freitas Caires, Nathalie, et al.
Publicado: (2018)

Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome
por: Erman, Hande, et al.
Publicado: (2020)

Endocan in Acute Leukemia: Current Knowledge and Future Perspectives
por: Reikvam, Håkon, et al.
Publicado: (2022)

Serum Endocan Levels and Subclinical Atherosclerosis in Behçet’s Syndrome
por: Nassef, Eman Mostafa, et al.
Publicado: (2022)

Refeeding syndrome in a woman with pancreatitis: a case report
por: Lo Gullo, Alberto, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dakr0jjn0idi2burotol2d27kb